These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1357272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. When urokinase was gone: commentary on another year of thrombolysis without urokinase.
    Gates J, Hartnell GG.
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):1-5. PubMed ID: 14709680
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM, Hoy C, Kong A, Gu SA, Greenberg D, Cook R, Chan SM, Ducas J.
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator.
    d'Ivernois C, Le Metayer P, Fischer B, Haissaguerre M, Warin JF.
    Chest; 1994 Apr; 105(4):1291-2. PubMed ID: 8162778
    [Abstract] [Full Text] [Related]

  • 10. Tissue plasminogen activator in acute pulmonary embolism.
    Goldhaber SZ.
    Chest; 1989 May; 95(5 Suppl):282S-289S. PubMed ID: 2495913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thrombolytic therapy for pulmonary embolism.
    Katchan BM.
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue plasminogen activator versus urokinase.
    Ebers GC.
    Lancet; 1988 Oct 29; 2(8618):1028. PubMed ID: 2902476
    [No Abstract] [Full Text] [Related]

  • 18. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR, Lucore CL, Eisenberg PR.
    Am J Med; 1994 May 29; 96(5):483-4. PubMed ID: 8192182
    [No Abstract] [Full Text] [Related]

  • 19. [Thrombolytic therapy of pulmonary embolism--a therapeutic alternative?].
    Gulba DC.
    Z Kardiol; 1993 May 29; 82 Suppl 2():29-34. PubMed ID: 8328206
    [Abstract] [Full Text] [Related]

  • 20. Evolving concepts in thrombolytic therapy for pulmonary embolism.
    Goldhaber SZ.
    Chest; 1992 Apr 29; 101(4 Suppl):183S-185S. PubMed ID: 1555483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.